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Abstract
The practice of endoscopy has been rapidly changing due to
new emerging technologies and novel techniques.  There has
been more focus on colonoscopy training with the development
of structured programmes including simulators.
Chromoendoscopy and magnification endoscopy have enabled
improved diagnosis of small neoplastic lesions and will be
important for the success of colorectal cancer screening
programmes.  The small bowel is now accessible to diagnostic
modalities like capsule endoscopy and to therapeutic tools
through the double balloon enteroscope.  Endoscopic therapy
has also become more sophisticated with endoscopic therapy
of reflux disease now possible. Excision of large colorectal
adenomatous polyps by endoscopic mucosal resection and
dissection of submucosal tumours may reduce the need for
surgical intervention.
The practice of endoscopy has rapidly changed over the past
few years.  What was once a simple diagnostic procedure made
possible by the development of fibre optics has become a
speciality in its own right.  This article will highlight some
aspects of endoscopic practice that have undergone major
changes over the past few years and that will shape endoscopy
practice in the future.
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Training
There has been a major overhaul of colonoscopy training in
the United Kingdom following the result of a large national
colonoscopy audit carried out in 1997.  The audit assessed
colonoscopy skills. The caecal intubation rate was only 56.7%
falling well below the standard of 90%.1  The results of the audit
reveal a deficiency in colonoscopy training and gave the
Department of Health the impetus to invest large sums of money
in colonoscopy training.  Three national centres were set up to
provide training with 7 supporting regional centres (Figure 1).
In addition, an endoscopy modernisation agenda for future
service development was established to compliment improved
training. A similar audit on ERCP practice is currently underway
and results are awaited.
Although the training methods may vary between the three
national centres they follow the same principles.  An
introduction to the instruments, with initial didactic tuition, is
followed by hands-on experience on endoscopy simulators,
which may be animal models, mannequins or computerised
programs.  Hands-on experience on patients is accompanied
by audio-visual recording of the trainee with a tri-split screen
looking at the endoscopic view, trainee’s handling of the scope
and a 3D-image of the configuration of the endoscope in the
third screen.  Generation of the 3D image was made possible by
the development of the ScopeGuide image (Figure 2), which
allows the endoscopist to monitor looping and locate the scope
without fluoroscopy and give feedback to the trainee on loop
correction. Imager colonoscopes differ from standard
colonoscopes in having sixteen or more 2mm in-built generator
coils. Each coil is energized 10 times/sec, by a field generator
connected to the scope by a cord plugged into the umbilicus.
Each coil then generates a magnetic field of different frequency,
which is then detected by larger coils in a sensor disk placed
alongside the patient.  The information is then analysed by a
signal processor converted into a graph and subsequently to a
3D image of the colonoscope, which can be seen on the monitor.
This technology is now available in most training units in the
UK.
With the impending introduction of colorectal cancer
screening for people over the age of 60, specialist accreditation
for gastroenterologists wishing to provide a screening service
may become necessary and specialist endoscopy training is likely
to become mandatory.
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New Technology
Diagnostics
Chromoendoscopy
Chromoendoscopy describes the application of stains or dye
through the endoscope to alter tissue appearance in order to
improve localisation, characterization or diagnosis of lesions.
The main dyes used in clinical and research practice are
methylene blue and indigo carmine.  Methylene blue enters the
cytoplasm of absorptive tissues such as colonic and small bowel
epithelia.  In the stomach it identifies intestinal metaplasia and
in the colon weak staining implies metaplastic, neoplastic, or
inflammatory change. Biopsies can then be targeted from areas
of intestinal metaplasia in Barrett’s oesophagus2 and from areas
of poor uptake in ulcerative colitis increasing the yield of
dysplasia.3
In contrast indigo carmine is not taken up by cells but
instead highlights the tissue surface by entering mucosal
depressions and crevices. It has been studied as a tool in the
assessment of the severity of ulcerative colitis and in the
identification of dysplastic lesions arising as complication of
longstanding ulcerative colitis.4   In non-colitis patients the
appearance of the surface pattern after the application of indigo
carmine has been shown to be useful to discriminate between
neoplastic and non-neoplastic polyps.5
Detection of diminutive polyps (polyps <5mm) has been
reported to be greater with dye spray compared to conventional
endoscopy.6
Magnification endoscopy
Although modern high resolution video-endoscopes permit
detailed views of the gastrointestinal mucosa, magnification
endoscopes can further enhance image detail. The Olympus
magnifying videoendoscope can magnify the mucosal surface
by 100 times and has been shown to provide an accurate
assessment of the histology of colorectal tumour.7  Kudo’s group
have shown that interpretation of the pit pattern by an expert
colonoscopist enabled a clinical decision on the best
management to be made without awaiting the histology (Figure
3).
Capsule endoscopy
Until recently, endoscopic visualisation of the small bowel
was limited to the upper jejunum by enteroscopy and the distal
end of the terminal ileum at colonoscopy. The limited access to
the small bowel at enteroscopy was largely due to the mobility
of the small intestine on its mesentery making fixation and
forward movement of the endoscope uncomfortable for the
patient. However, the introduction of the innovative wireless
Figure 1. Wolfson Unit for Endoscopy, one of the three UK
National Training Centres for endoscopy.  The centre offers
a 4-day accelerated colonoscopy course and Train the
Trainers course.  Additional courses on offer include basic
therapeutic skills and colonoscopy workshop.
Figure 2. ScopeGuide imager.  Specially designed
colonoscopes have inbuilt coils which are energised and
generate magnetic fields of different frequency. The magnetic
fields are detected by the round sensor disk, which is placed in
front of the patient.  Information from the disc is analysed to
produce a 3D image of the endoscope shown here in the top
screen. Trainees can modify their technique according to the
image on the screen.
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capsule endoscopy now allows easy, safe and effective small
bowel examination. This new technology consists of a capsule
(Pillcam®), a portable hard drive with antenna array (Given
system™) and a workstation (Rapid diagnostics®) (Figure 4).
The capsule contains a metal oxide silicon chip camera, a
short focal length lens, 4 white light emitting diode (LED)
illumination sources, two silver oxide batteries, and a UHF band
radio telemetry transmitter. It measures 11mm in diameter and
26 mm in length and is easily ingested by most patients.  It
weighs 3.7g and is passively propelled through the intestine by
peristalsis. The activated capsule provides image accrual and
transmission at a frequency of 2 frames per second until the
battery expires after 7 ± 1 hours. During the examination the
patient wears a belt pack holding a power supply containing
batteries together with a small 305gb hard drive for storing
received images. Before ingestion of the capsule, a series of
electrodes are taped to the patient’s abdomen in a designated
pattern. This is then connected to the hard drive on the belt so
that luminal findings can be correlated with general capsule
location in the abdomen.8   After eight hours, data are
downloaded from the belt pack recorder to a customized PC
workstation. Proprietary software is then used to review the
images and a report generated.
The diagnostic yield of capsule endoscopy has been shown
to be highest when used to investigate the cause of obscure
gastrointestinal bleeding.9   Its place in clinical practice is after
negative upper endoscopy, push enteroscopy, colonoscopy, and
possibly small bowel radiography. Other indications include
surveillance in patients with polyposis syndromes and
evaluation of malabsorptive, inflammatory or infiltrative
conditions. Our unit has undertaken 150 procedures and the
indications are listed in Table 1.  The diagnostic yield for obscure
gastrointestinal bleeding was 43% i.e. the cause for bleeding
was found in 43% of cases (unpublished data).  This is
comparable to the yield in a small series of 43 patients
investigated for obscure gastrointestinal bleeding9 but lower
than the yield of 47% reported in a larger series of 100 patients
with obscure bleeding.10  In two patients the investigation was
complicated by capsule retention necessitating surgery in one
case.
Therapeutics
The use of band ligation, injection therapy, heater probes
and argon plasma coagulators for haemostasis are widely
accepted practices together with other interventional procedure
such as polypectomy, percutaneous endoscopic gastrostomies,
stents and dilation. These simple therapeutic procedures are
leading the way to more invasive endo-surgical approaches to
treat gastrointestinal diseases.
Gastro-oesophageal reflux disease
The commonest surgical procedure used to control
gastrooesophageal reflux disease is the Nissen fundoplication
either laparoscopically or by an open technique.  However the
past few years have seen the introduction of a new surgical
approach via the endoscope also known as endoluminal
antireflux procedures.11  The site of intervention classifies these
procedures into one of three types: augmentation of the lower
Figure 4. Capsule endoscopy. The capsule is shown
compared to a dime coin.  The images from the capsule can
then be downloaded onto the computer and analysed using
the RAPID programme.  The view of the workstation is
shown here.
Figure 3.  Magnified view of a colonic polyp.  This image
shows a magnified polyp (x110) after the application of
indigo carmine dye spray.  The pit pattern resembles
cerebral sulci and is characteristic of an adenoma.  A normal
punctate pit pattern is shown inset.
Table 1.  Indications for capsule endoscopy from a series
of 150 patients
Number of cases (%)
Obscure Gastrointestinal bleeding 100 (66)
Peutz-Jeghers syndrome 30 (20)
Pain 10 (6.6)
Possible Crohn’s disease 4 (2.6)
Recurrence of Crohn’s disease 2 (1.3)
Other  (vomiting, Cowden’s disease
abnormal Barium imaging,
follow-up ileal carcinoma) 4 (2.6)
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Figure 5. Schematic view of endoscopic mucosal resection.
(a) The three main layers of the colonic wall are shown in
relation to a polyp. (b,c,d)  After a submucosal injection of
fluid the mucosa is lifted and the polyp is cushioned from the
underlying tissue. (e) The polyp can then be snared through
the submucosa.  (f) The polyp with a superficial surface of
the submucosa was then removed.
Figure 6. A polyp removed by endoscopic mucosal
resection. (a)  The polyp is first located (b) a mixture of
saline, adrenaline and methylene blue is injected in the
submucosal (c) the residual defect after polypectomy
showing the muscular layer.
oesophageal sphincter (usually by intramural injection of a
substance or placement of a device); suturing or plication
techniques; and radiofrequency ablation of the lower esophagus
and/or cardia.  Access to endoluminal therapies is still restricted
to use in clinical trials, as there remain a number of unresolved
features.  Questions about the underlying mechanisms of action,
the long-term efficacy and safety along with the appropriate
selection of patient for each technique need to be addressed
before they enter routine clinical practice.
Endoscopic mucosal resection
Endoscopic mucosal resection (EMR) completely removes
diseased mucosa by resecting through the middle or deeper part
of the submucosa. Although there are many variations of the
technique, the basic principle is the same – the diseased mucosa
is raised off the muscularis propria by the creation of a
submucosal bleb, strangulated by a snare or ligator, and
subsequently resected by an electrosurgical snare (Figure 5).
The purpose of EMR is twofold: to provide endoscopic cure of
early cancers in which the risk of lymph-node metastasis is
minimal and to obtain specimens for accurate pathologic
staging.  For all types of gastrointestinal cancers for the outcome
to be favourable there must be no evidence of venous or
lymphatic involvement.  In this context a useful discriminating
technique for colonic tumours as to whether it is amenable to
EMR removal is the effect of submucosal fluid injection.
Invasion, more than 2/3, into submucosa triggers substantial
submucosal fibrosis preventing tissue separation after attempts
at submucosal fluid injection (non-lifting sign).  The diagnostic
accuracy of the non-lifting sign in early cancer of the colon has
been investigated; one study has shown a positive predictive
value of 83% for invasive carcinoma.12
In the colon, the EMR is also used to safely remove flat
lesions and broad-based sessile polyps. Injection of fluid into
the submucosa beneath the polyp increases the distance between
the base of the polyp and the deeper tissues of the bowel wall.
The large submucosal cushion of saline solution increases the
safety of polypectomy by preventing thermal injury to these
deeper tissues.13   In our unit we have removed 177 polyps ranging
2-8cm in diameter with this technique with only one case
requiring hospitalisation for post-polypectomy bleeding (Figure
6). EMR can be safe, effective, and applicable to a variety of
clinical situations. If practiced in the right setting and with
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expertise, the technique should be considered in selected cases
of superficial early cancer in which the risk of leaving lymph
node metastases is nil or at least judged to be lower than the
risk of surgery or death.
En bloc resection techniques
En-bloc resection for adenomas, early mucosal cancers and
submucosal tumours using an insulated tip knife (IT knife) has
been reported for tumours of the upper GIT.  The advantages of
this approach are that the tumour can be resected in one piece
enabling completed histo-pathological assessment.  Less
recurrence has been reported when this procedure is used for
the removal of large colorectal polyps. 14  However further
comparative studies are warranted to confirm the safety and
efficacy of this technique.
The future
With the introduction of colorectal cancer screening
maximal detection of premalignant polyps will be of paramount
importance in the success of the program.  Confocal laser
endoscopy, in which a confocal laser microsope is intergrated
into the distal end of the endoscopy, permits the diagnosis of
neoplasia at endoscopy.15
  The clinical application of this new technology will probably
be as a two-stage procedure: firstly highlighting abnormal
mucosa by dye spray or autofluorescence followed by the
detailed examination using the confocal laser endoscope.
In the small bowel, progress in imaging has been made with
the introduction of the double balloon enteroscope which can
provide access to all the small bowel and now allows therapy
for lesions seen on capsule endoscopy.16
  Further technological improvements to the capsule
endoscope have been directed toward additional abilities, such
as means to label the bowel wall, sample the luminal contents,
biopsy the mucosa, or control the movement of the device.17
What was once believed to be science fiction is fast becoming a
reality.
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